β-thymosins

Annals of the New York Academy of Sciences

Volumn 1112, Issue , 2007, Pages 21-37

  Hannappel, E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Actin sequestering; Moonlighting; Thymosin fraction 5; Thymosin 4; Tissue repair; Wound healing

Indexed keywords

G ACTIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; THYMOSIN BETA4; THYMOSIN FRACTION 5;

AMINO ACID SEQUENCE; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; OXIDATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS;

VERTEBRATA;

EID: 35349003196     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1415.018     Document Type: Conference Paper

References (83)

1. KLEIN, J.J., A.L. GOLDSTEIN & A. WHITE. 1965. Enhancement of in vivo incorporation of labeled precursors into DNA and total protein of mouse lymph nodes after administration of thymic extracts. Proc. Natl. Acad. Sci. USA 53: 812-817.
2. GOLDSTEIN, A.L. et al. 1972. Purification and biological activity of thymosin, a hormone of the thymus gland. Proc. Natl. Acad. Sci. USA 69: 1800-1803.
3. LOW, T.L. & A.L. GOLDSTEIN. 1985. Thymosin fraction 5 and 5 A. Methods Enzymol. 116: 219-233.
4. 1 from calf thymus. J. Biol. Chem. 254: 981-986.
5. SCHLESINGER, D.H. & G. GOLDSTEIN. 1975. Molecular conservation of 74 amino acid sequence of ubiquitin between cattle and man. Nature 255: 42304.
6. GLICKMAN, M.H. & A. CIECHANOVER. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82: 373-428.
7. CIECHANOVER, A. 2005. Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting (Nobel lecture). Angew Chem. Int. Ed. Engl. 44: 5944-5967.
8. CIECHANOVER, A. et al. 1980. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. Proc. Natl. Acad. Sci. USA 77: 1365-1368.
9. 4. J. Biol. Chem. 257: 1000-1006.
10. 10 in rabbit tissues. Arch. Biochem. Biophys. 226: 388-392.
11. 4-like peptide in oocytes of Xenopus laevis. Arch. Biochem. Biophys. 260: 546-551.
12. 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc. Natl. Acad. Sci. USA 78: 1162-1166.
13. 4. J. Immunoassay 8: 203-217.
14. REBAR, R.W. et al. 1981. Thymosin stimulates secretion of luteinizing hormone-releasing factor. Science 214: 669-671.
15. 4 and endoproteinase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system. FEBS Lett. 274: 30-34.
16. AIDOUDI, S. et al. 1996. In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil. Br. J. Haematol. 94: 443-448.
17. LENFANT, M. et al. 1989. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc. Natl. Acad. Sci. USA 86: 779-782.
18. 4 and its derivative AcSDKP in cardiac healing after infarction. Am. J. Cardiovasc. Drugs. 6: 305-311.
19. 4. Proc. Natl. Acad. Sci. USA 79: 1708-1711.
20. 4-like peptides by high-pressure liquid chromatography. Anal. Biochem. 156: 390-396.
21. 10 by an intracellular protease and its influence on the interaction with G-actin studied by ultrafiltration. FEBS Lett. 414: 39-44.
22. HUFF, T. et al. 2001. β-Thymosins, small acidic peptides with multiple functions. Int. J. Biochem. Cell Biol. 33: 205-220.
23. HANNAPPEL, E. & T. HUFF. 2003. The thymosins - prothymosin α, parathymosin, and β-thymosins: structure and function. In Vitamins and Hormones. Vol. 66. G. Litwack, Ed.: 257-296. Academic Press/Elsevier Science. New York, NY.
24. HANNAPPEL, E., T. HUFF & D. SAFER. 2006. Intracellular β-thymosins In Actin Monomer Binding Proteins. P. Lappalainen, Ed.: 61-70. Landes Bioscience/Eurekah.com. Austin, TX.
25. HUFF, T., C.S.G. MÜLLER & E. HANNAPPEL. 1997. HPLC and postcolumn derivatization with fluorescamine. Isolation of actin-sequestering β-thymosins by reversed-phase HPLC. Anal. Chim. Acta. 352: 239-248.
26. 4: a ubiquitous peptide in rat and mouse tissues. Proc. Natl. Acad. Sci. USA 79: 2172-2175.
27. 4 in cell lines. Arch. Biochem. Biophys. 240: 236-241.
28. 4 by peritoneal macrophages and adherent spleen cells. Proc. Natl. Acad. Sci. USA 79: 4006-4009.
29. OTTO, A.M. et al. 2002. Chemotherapeutic drugs change actin skeleton organization and the expression of β-thymosins in human breast cancer cells. J. Cancer Res. Clin. Oncol. 128: 247-256.
30. 4 in human blood cells and serum. J. Chromatogr. 397: 279-285.
31. SAFER, D., R. GOLLA & V.T. NACHMIAS. 1990. Isolation of a 5-kDa actinsequestering peptide from human blood platelets. Proc. Natl. Acad. Sci. USA 87: 2536-2540.
32. 4 and Fx, an actinsequestering peptide, are indistinguishable. J. Biol. Chem. 266: 4029-4032.
33. 4-like peptides as assessed by the DNase I inhibition assay. Biol. Chem. Hoppe Seyler. 374: 117-122.
34. 4. EMBO J. 11: 4739-4746.
35. 4 with actin studied by equilibrium centrifugation, chemical cross-linking and viscometry. Eur. J. Biochem. 230: 650-657.
36. 4 and its influence on the interaction with G-actin studied by reverse-phase HPLC and postcolumn derivatization with fluorescamine. Anal. Chim. Acta. 352: 249-255.
37. CLARK, R.A. & S.J. KLEBANOFF. 1979. Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. J. Clin. Invest. 64: 913-920.
38. 2+ and glucose. Biochim. Biophys. Acta. 1121: 325-330.
39. TEH, L.C. et al. 1987. Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities. J. Biol. Chem. 262: 6472-6477.
40. CABREIRO, F. et al. 2006. Methionine sulfoxide reductases: relevance to aging and protection against oxidative stress. Ann. N. Y. Acad. Sci. 1067: 37-44.
41. PICOT, C.R. et al. 2006. Alterations in mitochondrial and cytosolic methionine sulfoxide reductase activity during cardiac ischemia and reperfusion. Exp. Gerontol. 41: 663-667.
42. 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat. Med. 5: 1424-1427.
43. SMITH, P. & D. HEATH. 1976. Paraquat. CRC Crit. Rev. Toxicol. 4: 411-445.
44. BALDWIN, R.C. et al. 1975. The rates of radical formation from dipyridylium herbicides paraquat, diquat, and morfamquat in homogenates of rat lung, kidney, and liver: an inhibitory effect of carbon monoxide. Toxicol. Appl. Pharmacol. 32: 298-304.
45. BUS, J.S., S.D. AUST & J.E. GIBSON. 1974. Superoxide- and singlet oxygen-catalyzed lipid peroxidation as a possible mechanism for paraquat (methyl viologen) toxicity. Biochem. Biophys. Res. Commun. 58: 749-755.
46. BUS, J.S. & J.E. GIBSON. 1984. Paraquat: model for oxidant-initiated toxicity. Environ. Health Perspect. 55: 37-46.
47. GRUNE, T. et al. 1995. Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J. Biol. Chem. 270: 2344-2351.
48. KAZZAZ, J.A. et al. 1996. Cellular oxygen toxicity. Oxidant injury without apoptosis. J. Biol. Chem. 271: 15182-15186.
49. SPERANZA, M.J., A.C. BAGLEY & R.E. LYNCH. 1993. Cells enriched for catalase are sensitized to the toxicities of bleomycin, adriamycin, and paraquat. J. Biol. Chem. 268: 19039-19043.
50. LI, W.D., Y.Z. ZHAO & I.N. CHOU. 1987. Paraquat-induced cytoskeletal injury in cultured cells. Toxicol. Appl. Pharmacol. 91: 96-106.
51. CAPPELLETTI, G. et al. 1996. Dynamic changes in the state of actin polymerization in human alveolar cells exposed to the oxidant agent paraquat. Eur. J. Cell Biol. 71: 293-302.
52. CAPPELLETTI, G. & R. MACI. 1993. Actin filaments disassembly: a novel step in the genesis of paraquat toxicity? Bull. Environ. Contam. Toxicol. 50: 717-723.
53. CAPPELLETTI, G., C. INCANI & R. MACI. 1994. Paraquat induces irreversible actin cytoskeleton disruption in cultured human lung cells. Cell Biol. Toxicol. 10: 255-263.
54. 4. FEBS Lett. 425: 495-498.
55. DALLEDONNE, I., A. MILZANI & R. COLOMBO. 1998. G-actin conformational change and polymerization induced by paraquat. Biochem. Cell Biol. 76: 583-591.
56. MILZANI, A. et al. 1997. Paraquat induces actin assembly in depolymerizing conditions. FASEB J. 11: 261-270.
57. 4 serves as a glutaminyl substrate of transglutaminase. Labeling with fluorescent dansylcadaverine does not abolish interaction with G-actin. FEBS Lett. 464: 14-20.
58. 4. J. Cell Sci. 117: 5333-5343.
59. GONSIOR, S.M. et al. 1999. Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody. J. Cell Sci. 112 (Pt. 6): 797-809.
60. SCHEER, U. et al. 1984. Microinjection of actin-binding proteins and actin antibodies demonstrates involvement of nuclear actin in transcription of lampbrush chromosomes. Cell 39: 111-122.
61. CAIRNS, B.R. et al. 1998. Two actin-related proteins are shared functional components of the chromatin-remodeling complexes RSC and SWI/SNF. Mol. Cell 2: 639-651.
62. HARATA, M., R. MOCHIZUKI & S. MIZUNO. 1999. Two isoforms of a human actinrelated protein show nuclear localization and mutually selective expression between brain and other tissues. Biosci. Biotechnol. Biochem. 63: 917-923.
63. HARATA, M. et al. 2000. Multiple actin-related proteins of Saccharomyces cerevisiae are present in the nucleus. J. Biochem (Tokyo). 128: 665-671.
64. GIESEMANN, T. et al. 1999. A role for polyproline motifs in the spinal muscular atrophy protein SMN. Profilins bind to and colocalize with smn in nuclear gems. J. Biol. Chem. 274: 37908-37914.
65. NOVAK, K.D. & M.A. TITUS. 1997.Myosin I overexpression impairs cell migration. J. Cell Biol. 136: 633-647.
66. PESTIC-DRAGOVICH, L. et al. 2000. A myosin I isoform in the nucleus. Science 290: 337-341.
67. SKARE, P. et al. 2003. Profilin I colocalizes with speckles and Cajal bodies: a possible role in pre-mRNA splicing. Exp. Cell Res. 286: 12-21.
68. RANDO, O.J., K. ZHAO & G.R. CRABTREE. 2000. Searching for a function for nuclear actin. Trends Cell Biol. 10: 92-97.
69. OLAVE, I.A., S.L. RECK-PETERSON & G.R. CRABTREE. 2002. Nuclear actin and actin-related proteins in chromatin remodeling. Annu. Rev. Biochem. 71: 755-781.
70. PEDERSON, T. & U. AEBI. 2005. Nuclear actin extends, with no contraction in sight. Mol. Biol. Cell 16: 5055-5060.
71. 4: actin sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 11: 421-429.
72. 4 gene in differentiating endothelial cells. J. Cell Sci. 108 (Pt. 12): 3685-3694.
73. 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J. 11: 474-481.
74. 4 accelerates wound healing. J. Invest. Dermatol. 113: 364-368.
75. 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp. Eye Res. 72: 605-608.
76. 4 suppression of corneal NFkB: a potential anti-inflammatory pathway. Exp. Eye Res. 84: 663-669.
77. 4 promotes angiogenesis, wound healing, and hair follicle development. Mech. Ageing Dev. 125: 113-115.
78. 4 increases hair growth by activation of hair follicle stem cells. FASEB J. 18: 385-387.
79. 4 mRNA following focal brain ischemia. Neuroreport 7: 1613-1616.
80. 4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432: 466-472.
81. 4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445: 177-182.
82. 4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen. FASEB J. 16: 691-696.
83. 4 preferentially into the fibrin(ogen) aC-domains. Biochemistry 43: 10748-10756.